rs5030977
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006030.4(CACNA2D2):c.1260+22G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0844 in 1,613,318 control chromosomes in the GnomAD database, including 6,375 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.065 ( 430 hom., cov: 33)
Exomes 𝑓: 0.086 ( 5945 hom. )
Consequence
CACNA2D2
NM_006030.4 intron
NM_006030.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.208
Publications
8 publications found
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
- cerebellar atrophy with seizures and variable developmental delayInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- complex neurodevelopmental disorderInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-50379070-C-T is Benign according to our data. Variant chr3-50379070-C-T is described in ClinVar as Benign. ClinVar VariationId is 1253361.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.092 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA2D2 | ENST00000424201.7 | c.1260+22G>A | intron_variant | Intron 12 of 37 | 1 | NM_006030.4 | ENSP00000390329.2 | |||
| CACNA2D2 | ENST00000423994.6 | c.1260+22G>A | intron_variant | Intron 12 of 38 | 5 | ENSP00000407393.2 | ||||
| CACNA2D2 | ENST00000266039.7 | c.1260+22G>A | intron_variant | Intron 12 of 37 | 1 | ENSP00000266039.3 | ||||
| CACNA2D2 | ENST00000360963.7 | c.1053+22G>A | intron_variant | Intron 12 of 37 | 1 | ENSP00000354228.3 |
Frequencies
GnomAD3 genomes AF: 0.0653 AC: 9943AN: 152170Hom.: 431 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
9943
AN:
152170
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0722 AC: 18094AN: 250722 AF XY: 0.0740 show subpopulations
GnomAD2 exomes
AF:
AC:
18094
AN:
250722
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0864 AC: 126175AN: 1461030Hom.: 5945 Cov.: 32 AF XY: 0.0852 AC XY: 61956AN XY: 726844 show subpopulations
GnomAD4 exome
AF:
AC:
126175
AN:
1461030
Hom.:
Cov.:
32
AF XY:
AC XY:
61956
AN XY:
726844
show subpopulations
African (AFR)
AF:
AC:
419
AN:
33470
American (AMR)
AF:
AC:
2098
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
AC:
3046
AN:
26128
East Asian (EAS)
AF:
AC:
3
AN:
39698
South Asian (SAS)
AF:
AC:
2880
AN:
86242
European-Finnish (FIN)
AF:
AC:
5267
AN:
53224
Middle Eastern (MID)
AF:
AC:
432
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
107239
AN:
1111418
Other (OTH)
AF:
AC:
4791
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
6717
13433
20150
26866
33583
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3760
7520
11280
15040
18800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0653 AC: 9937AN: 152288Hom.: 430 Cov.: 33 AF XY: 0.0640 AC XY: 4768AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
9937
AN:
152288
Hom.:
Cov.:
33
AF XY:
AC XY:
4768
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
673
AN:
41560
American (AMR)
AF:
AC:
975
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
417
AN:
3470
East Asian (EAS)
AF:
AC:
2
AN:
5190
South Asian (SAS)
AF:
AC:
133
AN:
4832
European-Finnish (FIN)
AF:
AC:
1012
AN:
10608
Middle Eastern (MID)
AF:
AC:
17
AN:
294
European-Non Finnish (NFE)
AF:
AC:
6390
AN:
68004
Other (OTH)
AF:
AC:
175
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
479
958
1438
1917
2396
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
58
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 10, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.